Needle

Buying and selling forest carbon as a commodity is dangerous if it trumps other environmental and social uses – new report

Retrieved on: 
måndag, juni 3, 2024

Globally, forests remove nearly all of the two billion tonnes of carbon dioxide that is currently being removed from the atmosphere every year.

Key Points: 
  • Globally, forests remove nearly all of the two billion tonnes of carbon dioxide that is currently being removed from the atmosphere every year.
  • International financiers estimate that by 2050, Africa could be selling US$1.5 trillion in carbon credits per year, mainly from its forests.
  • They have found that buying and selling forest carbon as a commodity is dangerous if it is prioritised over the other environmental and social uses of forests.

What is a carbon sink?

  • All living things contain carbon, and are considered carbon sinks when they absorb more carbon from the atmosphere than they release.
  • Many ecosystems serve as carbon sinks, but forests have a large biomass (wood and twigs and leaves on the forest floor).

Why is it a problem for a forest to be seen only as a carbon sink?

  • In Africa alone, an estimated 245 million people live within five kilometres of a forest, and many of these people rely directly on forests for their livelihoods.
  • * Read more: ‘Sacred forests’ in West Africa capture carbon and keep soil healthy * * Our research found that forests are increasingly being managed as carbon sinks, and the carbon they store treated as a commodity that can be internationally traded.
  • Carbon markets allow businesses and governments to earn credits by paying for forests that reduce greenhouse gas emissions, which is cheaper than reducing their own emissions.
  • This is especially threatening for people who do not have secure rights to the forests and land they depend on.
  • Research has found that forest-dependent communities are rarely given power to address their own priorities in forest carbon sink schemes.

What are some solutions?

Sharps Technology Positioned to Address Supply Chain Disruptions Resulting from Recent FDA Recalls, Warnings, and Tariffs on Chinese Manufactured Syringes

Retrieved on: 
tisdag, maj 28, 2024

NEW YORK, May 28, 2024 (GLOBE NEWSWIRE) -- Sharps Technology, Inc., (NASDAQ: “STSS” and “STSSW”), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class syringe products, issues a shareholder update from Robert Hayes, the Company’s Chief Executive Officer.

Key Points: 
  • Sharps CEO issues letter to shareholders on FDA actions and tariffs affecting Chinese syringes.
  • The tariff rate on Chinese-made syringes and needles was raised from 0% to 50% by the Biden Administration in May 2024.
  • In response to these developments, Sharps Technology is experiencing heightened interest in our syringe products, and we are actively pursuing these opportunities within the healthcare market.
  • Our innovative products, such as the SecureGard and SoloGard syringe lines, are designed to address the specific safety and performance concerns highlighted by the FDA .

Datyra, Inc. Announces the Release of The Corporatus 1.2: Advancing Scientific Discovery With a Specially Trained Model for Scientific Research

Retrieved on: 
tisdag, maj 28, 2024

The Corporatus team is thrilled to announce the launch of The Corporatus 1.2, the latest iteration of our cutting-edge language model designed specifically for scientific research.

Key Points: 
  • The Corporatus team is thrilled to announce the launch of The Corporatus 1.2, the latest iteration of our cutting-edge language model designed specifically for scientific research.
  • Corporatus was trained on the literature of Da Vinci and Edmund Burke to incorporate their personalities and then trained again to perform its scientific tasks.
  • Expansion of Literature Database: The Corporatus’ scientific database has increased to over 100,000 papers and the size of the database will continue to grow with the enhancements in the 1.2 release.
  • Experience the future of scientific research with The Corporatus 1.2.

Over 130 Resident Dermatologists Receive In-Depth Cosmetic Training From Renowned ASDS Member Physicians

Retrieved on: 
onsdag, maj 22, 2024

Career Paths

Key Points: 
  • Career Paths
    The course agenda is purposefully scheduled with dedicated time for networking breaks and visiting industry partners in the exhibit area.
  • Additionally, residents enjoyed a welcome reception on Friday evening to mingle with the renowned faculty and industry supporters, as well as a carnival-themed reception hosted by La Roche-Posay on Saturday.
  • This was a fantastic learning opportunity, especially for upper-level residents who have had some hands-on experience and have thus had the opportunity to generate questions.
  • Another echoed, “The current curriculum at my home program has minimal exposure to cosmetic procedures, yet they are required for examination purposes.

Project Red Phoenix Soars: ECD Automotive's Defender 110 Lands in Denver, Colorado

Retrieved on: 
tisdag, maj 14, 2024

KISSIMMEE, Fla., May 14, 2024 (GLOBE NEWSWIRE) -- ECD Auto Design, the world’s largest Land Rover and Jaguar restoration company known for its custom luxury builds, including bespoke Defenders, Range Rovers, Jaguar E-Types, and Ford Mustangs, proudly delivers Project Red Phoenix to its new Colorado home.

Key Points: 
  • The new 110 Defender is planned to see plenty of adventure from towing a trailer for family camping trips to trekking up the Colorado mountains and with its LS3 430 HP 6.2L engine, Project Red Phoenix will pack plenty of power to take on any challenge.
  • To further enhance its capabilities, the vehicle is outfitted with a 6-point external roll cage, top mounted spotlights, ladder, and 10,000 lb.
  • The beauty of the Red Phoenix continues when you open the door and see all the luxurious accents and details from its Corbeau Trailcat seats to custom cluster.
  • Project Red Phoenix has several unique custom features that truly set it apart including its right-hand driver’s compartment, vintage black wood paneling, cargo flooring and hidden floor lockbox.

Retractable Technologies, Inc. Results for the Period Ended March 31, 2024

Retrieved on: 
onsdag, maj 15, 2024

Unrealized gains on investments were a significant factor in the computation of net income for the first quarter of 2024.

Key Points: 
  • Unrealized gains on investments were a significant factor in the computation of net income for the first quarter of 2024.
  • Retractable reports that domestic demand may be depressed due to the retention of products previously provided for vaccination purposes in customers’ inventory.
  • Retractable’s Form 10-Q filed on May 15, 2024 additionally reports that a new 50% tariff on syringes and needles will likely take effect in the third quarter of 2024.
  • Retractable experienced significant growth in late 2020 through early 2022 due to material orders from the U.S. government to supply syringes for COVID-19 vaccination efforts.

Lumenis' triLift Awarded "Best New Dermatology Technology Solution" in 8th Annual MedTech Breakthrough Awards Program

Retrieved on: 
fredag, maj 10, 2024

YOKNE'AM ILLIT, Israel, May 10, 2024 /PRNewswire/ -- Lumenis Be Ltd., a leading energy-based medical device company for aesthetic and eye care applications, announced today that triLift is the winner of the highly competitive "Best New Dermatology Technology Solution" award in the 8th annual MedTech Breakthrough Awards program.

Key Points: 
  • YOKNE'AM ILLIT, Israel, May 10, 2024 /PRNewswire/ -- Lumenis Be Ltd., a leading energy-based medical device company for aesthetic and eye care applications, announced today that triLift is the winner of the highly competitive "Best New Dermatology Technology Solution" award in the 8th annual MedTech Breakthrough Awards program.
  • triLift's Dynamic Muscle Stimulation technology (DMSt™) stimulates muscle contractions, mimicking physiological muscle function at a significantly higher frequency and intensity.
  • Previously, the only options masked the issue without addressing a root cause – facial muscle mass," said Steve Johansson, managing director, MedTech Breakthrough.
  • The mission of the MedTech Breakthrough Awards is to honor excellence and recognize the innovation, hard work and success in a range of health and medical technology categories.

Boehringer Ingelheim receives Health Canada approval for SENVELGO™, the once-daily liquid oral solution for newly diagnosed diabetes in cats

Retrieved on: 
tisdag, maj 7, 2024

SENVELGO™ (velagliflozin oral solution) is the first once-daily liquid oral solution to improve glycemic control in newly diagnosed cats with diabetes mellitus.

Key Points: 
  • SENVELGO™ (velagliflozin oral solution) is the first once-daily liquid oral solution to improve glycemic control in newly diagnosed cats with diabetes mellitus.
  • SENVELGO™ is the first once-daily liquid oral solution for the reduction of hyperglycemia in cats with non-insulin-dependent diabetes mellitus.
  • Pet owners can give the once-daily liquid oral solution with a small amount of food or directly into the cat's mouth.
  • Dr. Walt Ingwersen, Technical Services Veterinarian with Boehringer Ingelheim Canada, said SENVELGO™ revolutionizes the treatment and management of feline diabetes in newly diagnosed cats.

Cheung Aesthetics & Wellness Introduces Cutting-Edge Technology to Reverse Aging Without Pain or Downtime

Retrieved on: 
torsdag, maj 2, 2024

Data shows that for most effective results in reducing wrinkles, lifting muscles, and improving facial contour, patients need four treatments of EMface -- one per week. Optimal results are noticeable 6 to 12 weeks after the last treatment.

Key Points: 
  • WILLOWBROOK, Ill., May 2, 2024 /PRNewswire/ -- Cheung Aesthetics & Wellness , a leading Chicago dermatology practice, is among the first to offer groundbreaking technology that reverses facial aging and reduces wrinkles without discomfort, needles, or downtime.
  • The clinic is hosting "Spring Showcase," a complimentary beauty/makeover event on May 16 for those who want to try the latest technology.
  • "EMface is the wave of the future for those wanting to reverse aging using a non-invasive, painless procedure with no bruising or downtime.
  • The EXION platform also features a painless, radiofrequency micro-needling technology that targets hard to treat areas without discomfort or bruising.

$3.84 Bn Biopsy Devices Market, Size, Global Forecast Report 2024-2030 Featuring Cardinal Health, Hologic, Danaher, BD and Co, Boston Scientific, Medtronic, Olympus, and CONMED - ResearchAndMarkets.com

Retrieved on: 
tisdag, april 23, 2024

The increasing occurrence of cancers globally drives growth within the biopsy devices market.

Key Points: 
  • The increasing occurrence of cancers globally drives growth within the biopsy devices market.
  • Innovations like Vacora, Finesse Ultra Breast Biopsy System, and Celero VAB gadgets will bolster the boom trajectory of the biopsy devices market.
  • The biopsy devices market is segmented based on application into Breast Biopsy, Lung Biopsy, Prostate Biopsy, Liver Biopsy, Gastroenterology Biopsy, and Others.
  • Due to their superior imaging technologies and specialized information, diagnostic and imaging facilities are among the segments gaining traction within the global biopsy devices market.